Home › Lung Diseases › Minnesota › Saint Paul
Lung Diseases clinical trials in Saint Paul, MN
3 studies for Lung Diseases are looking for participants at sites in and around Saint Paul (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
- Headlands Research-Twin Cities, Maplewood · 5 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- HealthPartners Cancer Research Center, Saint Paul
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Saint Paul
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Saint Paul
- Non-Small Cell Lung Cancer20 studies
- Prostate Cancer14 studies
- Lung Cancer13 studies
- Breast Cancer12 studies
- Colorectal Cancer9 studies
- Ovarian Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Endometrial Cancer7 studies
- Metastatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Obesity6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.